Furthermore, similarly to other examples of targeted therapy based on deficient DNA repair mechanisms 25, 26, it would be important to explore how the hypermutated phenotype associated with POLE mutations may be used therapeutically, especially in the context of advanced CRC. The gene discussed is POLE; the disease is colorectal carcinoma.